Alucent Biomedical Wins FDA Approval for U.S. Clinical Study
U.S. FDA Grants an Investigational Device Exemption for Trial Evaluating Novel AlucentNVS Technology
Posted in BioUtah News
Tagged Alucent Biomedical
Comments Off on Alucent Biomedical Wins FDA Approval for U.S. Clinical Study
Alucent Biomedical Announces First Patient Enrolled in First in Human Natural Vascular Scaffolding Clinical Trial
Multicenter ACTIVATE II Study to Enroll up to 50 Patients in Australia
